Skip to main content

Method-specific differences in plasma fibroblast growth factor 23 measurement using four commercial ELISAs.

Smith ER, McMahon LP, Holt SG

Publication: Clin Chem Lab Med (2013) • Vol 51 • Page 1971-81PMID: 23729624View on PubMed

Purpose

The purpose of this paper was to determine the effects of delayed centrifugation, tube type, assay manufacturer and assaying intact (i) rather than c-terminal (c) fibroblast growth factor 23 (FGF23) in plasma and serum from healthy individuals and those on hemodialysis therapy.

Conclusion

Intact FGF23 (iFGF23) concentrations declined when whole blood was stored for 8 h in plain tubes before centrifugation rather than centrifuged immediately, but the difference was smaller when assayed using the Millipore or Kainos kit than the Immunotopics kit, and cFGF23 levels were unaffected. Further, delayed centrifugation of specimens in P100 tubes did not impact iFGF23 levels. Mean FGF23 was slightly higher in plasma than serum (Kainos kit used). The Millipore iFGF23 assay was less sensitive than the Kainos and Immunotopics iFGF23 assays, but the concentration of endogenous FGF23 was higher when measured using the Kainos kit than the Immunotopics or Millipore kits. When plasma was spiked with FGF23, the Immuntopics kit measured higher levels than expected when spiked with 260 pg/mL, but it was accurate at 20 pg/mL and 80 pg/mL. In contrast, the Millipore and Kainos kits measured lower levels of FGF23 than expected at all concentrations, with a larger underestimation at 260 pg/mL. FGF23 levels determined using the Immunotopics cFGF23 assay were not significantly correlated with levels determined using any of the three iFGF23 assays.

Studies (1)

Purpose

The purpose of this study was to determine the effects of delayed centrifugation, tube type, assay manufacturer and targeting intact rather than c-terminal protein on measured levels of FGF23 in plasma and serum from healthy individuals and those on hemodialysis therapy. For stability studies, blood was collected into plain tubes and P100 tubes, but for all other comparisons, blood was collected into P100 or serum gel tubes.

Summary of Findings

iFGF23 concentrations declined when whole blood was stored for 8 h in plain tubes before centrifugation rather than being centrifuged immediately, but the difference was smaller when assayed using the Millipore (7%, p=0.0001) or Kainos (5%, p=0.016) kits than the Immunotopics kit (23%, p=0.001), and there was no effect on cFGF23 levels. Further, delayed centrifugation of specimens in P100 tubes did not impact iFGF23 levels. Mean FGF23 was slightly higher in plasma than serum as measured by the Kainos kit (43.8 vs 40.2, p=0.015). The Millipore iFGF23 assay showed smaller changes in absorbance with increasing FGF23 concentrations resulting in lower sensitivity than the Kainos and Immunotopics iFGF23 assays. The concentration of endogenous FGF23 was higher when measured using the Kainos kit than the Immunotopics or Millipore kits, and this disparity increased with increasing FGF23 concentration such as those found in the patients undergoing hemodialysis therapy. When plasma was spiked with FGF23, the Immuntopics kit measured higher levels than expected when spiked with 260 pg/mL, but was accurate at 20 pg/mL and 80 pg/mL. In contrast, the Millipore and Kainos kits measured lower levels of FGF23 than expected at all concentrations, with a larger underestimation at 260 pg/mL. FGF23 levels determined using the Immunotopics cFGF23 assay were not significantly correlated with levels determined using any of the three iFGF23 assays.

  • Biospecimens

    FluidBlood
    FluidPlasma
    FluidSerum
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
    Other diagnoses
  • Platforms

    ProteinELISA
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Undergoing chronic hemodialysis therapy
    Biospecimen AcquisitionType of collection container/solution
    P100 tube
    Plain tube
    Biospecimen Aliquots and ComponentsBiospecimen components
    20 pg/mL
    260 pg/mL
    80 pg/mL
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    StorageStorage duration
    0 h
    8 h
    StorageType of storage container
    P100 tube
    Plain tube
    ELISA SpecificTechnology platform
    Immunotopics cFGF23
    Immunotopics iFGF23
    Kainos iFGF23
    Millipore iFGF23